Minerva Neurosciences NERV
NASDAQ NERV
$3.38 +0.03 (+0.75%)
As of: Sep 30, 2026 · 10:08 AM EDT

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014)

Updated

Minerva Neurosciences' Interest Coverage Ratio came in at -10.22 for Q2 2014.

Analysis

Minerva Neurosciences (NERV) Interest Coverage Ratio (2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Interest Cover (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 25.41
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn -
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn -
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 10.28
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn 7.27
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 5.22
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Minerva Neurosciences 160.57 Mn 160.57 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 -10.22
API Access

Minerva Neurosciences Interest Coverage Ratio API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=interest-coverage-ratio&ticker=NERV&period=max&api_key=YOUR_API_KEY